Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Unknown 3Completed 3Withdrawn 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 2Genitourinary 1

Conditions

Febrile Neutropenia 2Urinary Bladder Neoplasms 1Sepsis 1Neoplasms 1Fever 1Emergencies 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Meropenem × Clear all
NCT05393505 2022-12-06

FRANCiS-NF

The University of Hong Kong

Phase 4 Unknown
344 enrolled
Classical hematology

Emergencies, Neoplasms, Sepsis, Febrile Neutropenia

NCT05392634 2022-05-31

MACS

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Unknown
98 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02463747 2015-06-04

RR

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
110 enrolled
Classical hematology

Fever, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡